Budapest, Hungary

Magdolna Kenyeres Nee Feher


Average Co-Inventor Count = 17.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 1995

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Magdolna Kenyeres: Pioneering Pharmaceutical Innovator

Introduction

Magdolna Kenyeres nee Feher, a distinguished inventor based in Budapest, Hungary, has made significant contributions to the field of pharmaceuticals. With a patent to her name, she has played a vital role in developing innovative processes that enhance medical treatments.

Latest Patents

Her notable patent relates to a process for the preparation of 6,7-dichloro-1,5-dihydroimidazo[2,1-b]-quinazolin-2[3H]-one, commonly known as anagrelide. This compound serves as a valuable blood platelet antiaggregative agent. The innovative process involves the thermal cyclization of a new 2-cyanoiminoquinazoline derivative in an acidic medium, significantly improving the efficiency and scalability of anagrelide production. This advancement addresses the limitations of previous methods, allowing for industrial-scale production.

Career Highlights

Magdolna is associated with Egis Gyogyszergyar, a reputable pharmaceutical company where she continues to contribute to research and development in the field. Her work exemplifies her commitment to improving healthcare through innovative scientific solutions.

Collaborations

In her career, Magdolna has collaborated with esteemed colleagues such as Jozsef Reiter and Peter Trinka. Together, they have explored and developed various pharmaceutical innovations, enhancing the capability to deliver effective medical treatments.

Conclusion

Magdolna Kenyeres's contributions to the pharmaceutical industry through her innovative patent represent a significant leap forward in medical chemistry. Her work not only demonstrates her talent as an inventor but also her dedication to improving healthcare solutions for the future.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…